Advertisement

Topics

Terveystalo group interim report 1 January-30 September 2017

02:30 EST 14 Nov 2017 | GlobalNewsWire (2014)

This article has expired, however you can still download the PDF.
Preview:
Terveystalo Plc Interim report 14 November at 8:30 a.m. EET Terveystalo group interim report 1 January-30 September 2017 Acquisitions and broad based organic growth increased revenue by 30.4% year-on-year...

Other Sources for this Article

NEXT ARTICLE

More From BioPortfolio on "Terveystalo group interim report 1 January-30 September 2017"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biotechnology Business
Alliances Astrazeneca Bioethics Boehringer Clinical Research Organization Collaborations GSK Johnson & Johnson Lilly Merck Mergers and Acquisitions Nexium Novartis Pfizer Roche Sanofi ...

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Alliances, mergers acquisitions and partnerships
BioPortfolio's alliances, mergers acquisitions and partnerships channel provides the latest news and corporate information on the global bio-pharmaceutical industry.